US Pharmacogenomics Market Summary
The US Pharmacogenomics market is projected to grow from 12.5 USD Billion in 2024 to 35 USD Billion by 2035, reflecting a robust CAGR of 9.81%.
Key Market Trends & Highlights
US Pharmacogenomics Key Trends and Highlights
- The market valuation is expected to reach 12.5 USD Billion in 2024.
- By 2035, the market is anticipated to expand to 35 USD Billion.
- The compound annual growth rate from 2025 to 2035 is projected at 9.81%.
- Growing adoption of personalized medicine due to increasing awareness of genetic testing is a major market driver.
Market Size & Forecast
| 2024 Market Size | 12.5 (USD Billion) |
| 2035 Market Size | 35 (USD Billion) |
| CAGR (2025 - 2035) | 9.81% |
Major Players
Apple Inc (US), Microsoft Corp (US), Amazon.com Inc (US), Alphabet Inc (US), Berkshire Hathaway Inc (US), Meta Platforms Inc (US), Tesla Inc (US), Johnson & Johnson (US), Visa Inc (US), Procter & Gamble Co (US)
